USE OF 2.6 NG/ML PROSTATE SPECIFIC ANTIGEN PROMPT FOR BIOPSY IN MEN OLDER THAN 60 YEARS-Reference-Cited by-同舟云学术

USE OF 2.6 NG/ML PROSTATE SPECIFIC ANTIGEN PROMPT FOR BIOPSY IN MEN OLDER THAN 60 YEARS

Published:2005-12 Issue:6 Volume:174 Page:2154-2157
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

NADLER ROBERT B.¹,LOEB STACY¹,ROEHL KIMBERLY A.¹,ANTENOR J.O. ANN V.¹,EGGENER SCOTT¹,CATALONA WILLIAM J.¹

Affiliation:

1. From the Department of Urology, Northwestern University, Feinberg School of Medicine (RBN, SL, SE, WJC), Chicago, Illinois, and Departments of Psychiatry (KAR), Neurology (JAVA) and Surgery/Urology (WJC), Washington University, St. Louis, Missouri

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference22 articles.

1. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter;Thompson;N Engl J Med,2004

2. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests;Ohori;J Urol,1994

3. Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features;Krumholtz;Urology,2002

4. Prostate cancer detection at low prostate specific antigen;Schröder;J Urol,2000

5. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves;Catalona;J Urol,1994

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytotherapy in Prostatitis: a Review on the Most Important Medicinal Plants Affecting Prostatitis in Iranian Ethnobotanical Documents;Plant Biotechnology Persa;2021-12-01

2. A discussion on controversies and ethical dilemmas in prostate cancer screening;Journal of Medical Ethics;2020-07-06

3. Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS;Scientific Reports;2018-04-03

4. Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2016-04

5. Perioperative and continence outcomes of robotic radical prostatectomy in elderly Indian men (≥70 years): A sub-group analysis;Indian Journal of Urology;2015